[go: up one dir, main page]

AU2001286663A1 - Metal radionuclide labelled cd-30 antibodies and uses thereof - Google Patents

Metal radionuclide labelled cd-30 antibodies and uses thereof

Info

Publication number
AU2001286663A1
AU2001286663A1 AU2001286663A AU8666301A AU2001286663A1 AU 2001286663 A1 AU2001286663 A1 AU 2001286663A1 AU 2001286663 A AU2001286663 A AU 2001286663A AU 8666301 A AU8666301 A AU 8666301A AU 2001286663 A1 AU2001286663 A1 AU 2001286663A1
Authority
AU
Australia
Prior art keywords
antibodies
metal radionuclide
radionuclide labelled
labelled
metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286663A
Inventor
Fook Thean Lee
Michael Pereundschuh
Christoph Renner
Andrew Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Cancer Research filed Critical Ludwig Institute for Cancer Research Ltd
Publication of AU2001286663A1 publication Critical patent/AU2001286663A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1021—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against cytokines, e.g. growth factors, VEGF, TNF, lymphokines or interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2001286663A 2000-08-28 2001-08-23 Metal radionuclide labelled cd-30 antibodies and uses thereof Abandoned AU2001286663A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64948900A 2000-08-28 2000-08-28
US09/649,489 2000-08-28
PCT/US2001/026335 WO2002017970A2 (en) 2000-08-28 2001-08-23 Metal radionuclide labelled cd-30 antibodies and uses thereof

Publications (1)

Publication Number Publication Date
AU2001286663A1 true AU2001286663A1 (en) 2002-03-13

Family

ID=24605007

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286663A Abandoned AU2001286663A1 (en) 2000-08-28 2001-08-23 Metal radionuclide labelled cd-30 antibodies and uses thereof

Country Status (2)

Country Link
AU (1) AU2001286663A1 (en)
WO (1) WO2002017970A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007437A2 (en) * 1989-11-20 1991-05-30 Parker, David, L. Improved cd-30 antibodies and fragments thereof
US5165923A (en) * 1989-11-20 1992-11-24 Imperial Cancer Research Technology Methods and compositions for the treatment of hodgkin's disease
AU4953693A (en) * 1992-08-25 1994-03-15 Medac Gesellschaft Fur Klinische Spezialpraparate Mbh Antibody/radioisotope conjugate for tumor diagnosis and/or therapy

Also Published As

Publication number Publication date
WO2002017970A3 (en) 2003-01-09
WO2002017970A2 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
IL154325A (en) Isolated anti-il-12 antibody and composition comprising the same
GB0029360D0 (en) Humanised antibodies and uses thereof
GB0123278D0 (en) Labelled articles and uses thereof
EP1071458A4 (en) Humanized antibody and uses thereof
IL158643A (en) Anti-hmg monoclonal antibodies and compositions containing the same
ZA200207589B (en) Multivalent antibodies and uses therefor. Multivalent antibodies and uses thereof.
AU4351201A (en) Heparinase iii and uses thereof
IL206832A0 (en) Antibodies binding an 161p2f10b epitope and uses thereof
GB9927332D0 (en) Novel antibody and uses thereof
AU2608602A (en) Silensed anti-cd28 antibodies and use thereof
GB0111218D0 (en) Assays methods and means
GB0122724D0 (en) Trx1 antibody and uses therefor
EP1302770A4 (en) Particle-labeled protein and immuno-chromatograph using the same
AU2001286663A1 (en) Metal radionuclide labelled cd-30 antibodies and uses thereof
IL153740A0 (en) Grf2-binding proteins and applications thereof
GB0010191D0 (en) Assays, methods and means
GB0128964D0 (en) Assays, methods and means
AU2001295337A1 (en) E. histolytica-specific antibodies and clinical uses thereof
IL201947A (en) Isolated replikin antibody and a composition comprising the same
AU2002338089A1 (en) Antibody and use thereof
AU1734701A (en) Antibody against human kgf
AUPQ599300A0 (en) Monoclonal antibody and uses therefor
AU2002239068A1 (en) Antibody and utilization thereof
AU2002230154A1 (en) Antibody and utilization thereof
GB0123261D0 (en) Assays methods and means